Abstract | OBJECTIVE: METHOD: Comprehensive administrative data and clinician survey were used to identify all patients with a DSM-IV diagnosis of schizophrenia who received long-acting antipsychotic prescriptions from July 2009 to June 2010 at a community mental health center. Charts were reviewed retrospectively to validate long-acting antipsychotic prescription (eg, medication, dosage) and merged with administrative data from all center patients documenting sociodemographic characteristics (ie, age, race, gender) and comorbid diagnoses. We used bivariate χ2, t tests, and multivariate logistic regression to compare the subsample of patients receiving long-acting injectable drugs (n = 102) to patients not receiving long-acting injectable drugs (n = 799) who were diagnosed with schizophrenia for the same period. RESULTS: CONCLUSIONS: Racial minorities are more likely than other patients with schizophrenia to receive long-acting injectionable antipsychotics, a finding that suggests their prescribers may consider them less adherent to antipsychotic prescriptions.
|
Authors | Neil Krishan Aggarwal, Robert A Rosenheck, Scott W Woods, Michael J Sernyak |
Journal | The Journal of clinical psychiatry
(J Clin Psychiatry)
Vol. 73
Issue 4
Pg. 513-7
(Apr 2012)
ISSN: 1555-2101 [Electronic] United States |
PMID | 22579151
(Publication Type: Journal Article)
|
Copyright | © Copyright 2012 Physicians Postgraduate Press, Inc. |
Chemical References |
- Antipsychotic Agents
- Delayed-Action Preparations
|
Topics |
- Antipsychotic Agents
(administration & dosage, therapeutic use)
- Black People
(statistics & numerical data)
- Chi-Square Distribution
- Community Mental Health Centers
(statistics & numerical data)
- Delayed-Action Preparations
- Female
- Healthcare Disparities
- Humans
- Logistic Models
- Male
- Middle Aged
- Psychotic Disorders
(drug therapy)
- Racial Groups
(statistics & numerical data)
- Retrospective Studies
- Schizophrenia
(drug therapy)
- White People
(statistics & numerical data)
|